Kenilworth-based Merck and Immune Design announced on Thursday the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Design.
Read the full story
February 18, 2019
More from This Week's Issue
© 2019 BridgeTower Media. All information on this site is copyrighted by BridgeTower Media.
All images are the sole property of BridgeTower Media and no rights are granted for any use without the express written consent of BridgeTower Media.